Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Rank in Stocks #41013
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Share Price
$0.00185055
Market Cap
$48.29K
Change (1 day)
-3.55%
Change (1 year)
30.31%
Country
GB
Trade Nuformix plc (NFX)

Category

Dividend yield history for Nuformix plc (NFX)
Nuformix plc (stock symbol: NFX) dividend yield (TTM) as of 2024-09-30: 0.00%
Average dividend yield, last 5 years : 0.00%
Dividend yield history for Nuformix plc (NFX) from 2014 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
2026 (TTM) 0.00% 0.00%
2025 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2014 0.00% 0.00%
Dividend yields (TTM) for similar companies or competitors
Company Dividend Yield Country
0.00%
US
0.00%
US
2.36%
AU
0.00%
NL
0.00%
CH